Showing results (171-180 of 1,027) with videos related to
Sort By:
Pageof 103
Expert Review of Anticancer Therapy|May 19, 2012
Pathogenesis and management of primary CNS lymphomaPatrick Roth, Agnieszka Korfel, Peter Martus, et al.Anticancer Research|September 12, 2013
APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cellsGünter Eisele, Fabian Wolpert, Guillaume Decrey, et al.Journal of Neuro-Oncology|November 12, 2018
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximodRimas V Lukas, Csaba Juhász, Derek A Wainwright, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 18, 2005
Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLCEdgardo Pezzetta, Roger Stupp, Abderrahim Zouhair, et al.Cancer Chemotherapy and Pharmacology|July 1, 2008
A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascitesAndrea Kuemmerle, Laurent A Decosterd, Thierry Buclin, et al.Nature Reviews. Clinical Oncology|June 18, 2014
European perspective for effective cancer drug developmentDenis Lacombe, Sabine Tejpar, Roberto Salgado, et al.Neuro-Oncology Advances|December 15, 2025
Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profileYufan Yang, Nitin Wadhwani, Yuki Aoi, et al.Chemotherapy|October 27, 2015
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade GliomaMichaela Tonder, Michael Weller, Günter Eisele, et al.Current Neurology and Neuroscience Reports|February 1, 2011
Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidenceWolfgang Wick, Antje Wick, Markus Weiler, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2012
Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case reviewAlysa Fairchild, Damien C Weber, Raquel Bar-Deroma, et al.Pageof 103